Dr Nipun Verma @drnipunverma

Clinician hepatologist, devoted to patient care, research and teaching, #AI, #EBM, #infections #liver failure #Omics #statistics #one world one family Pgimer chandigarh Joined November 2023

Tweets

2K
Followers

774
Following

762
Likes

3K

Sayan @sayan006GI

5 hours ago

🚨New pub alert : Refractory AIH 🔔 Pathophysiological targets 🔖Work-up ⚠️ Comparison of safety and efficacy : 2nd and 3rd line therapy 📝 Outcome Coauthored by @umairshams @giri_gutnliver Read here wjgnet.com/1948-5182/full…

1 4 12 476 2

Download Image

Eric Topol @EricTopol

2 days ago

A new large study of alcohol intake using genetics (Mendelian randomization) finds a dose-response relationship for risk of dementia with no protective effect at low levels of intake ebm.bmj.com/content/early/…

23 127 517 60K 198

Download Image

Kohilan Gananandan @KGananandan

2 days ago

🚨 Excited to announce the next @uk_torch project #EVADE is now live! Please sign up below, we want as much representation as possible all over the UK 🇬🇧. redcap.mft.nhs.uk/surveys/?__das… @BSGTrainees @BASLedu @WAGE_media @OTavabie @jamesbmaurice @VSAthwal @sheiybani @ChrisMysko

0 6 9 1K 1

Download Image

Dr Nipun Verma @drnipunverma

a day ago

Great initiative..Best wishes..

Kohilan Gananandan @KGananandan

2 days ago

Great initiative..Best wishes..

0 6 9 1K 1

Download Image

0 0 3 453 0

Dr Nipun Verma @drnipunverma

3 days ago

Impact of Saroglitazar on Liver Stiffness Measurements in Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) With Compensated Cirrhosis: A Single-Arm Study | Cureus ⁦@RoyAHep⁩ ⁦@INASL_Liver⁩ ⁦@ajay_duseja⁩ cureus.com/articles/38644…

0 4 13 512 1

Elliot Tapper @ebtapper

4 days ago

@drsuniltaneja @drnipunverma @RajivJalan1 @JasmohanBajaj @ajay_duseja @doc_arka @SahajRathi ... if any ... is going to be small and observed only in the most carefully selected patient, almost without resemblance to the typical patient we treat

1 1 3 157 0

Elliot Tapper @ebtapper

4 days ago

@drsuniltaneja @drnipunverma @RajivJalan1 @JasmohanBajaj @ajay_duseja @doc_arka @SahajRathi Many valid points. These trials are challenging, as you know. But I dont think we can just wave these data away. In fact, ARiE did not observe any difference in mortality and the subgroup you highlight suffers from the same lack of power in the criticism. The effect of rif...

1 1 5 326 0

Sunil Taneja @drsuniltaneja

4 days ago

Too sick to benefit? Patient selection and timing in the ProPILA-Rifax trial - Journal of Hepatology journal-of-hepatology.eu/article/S0168-… @ebtapper @drnipunverma @RajivJalan1 @JasmohanBajaj @ajay_duseja @doc_arka @SahajRathi

1 4 9 605 0

Dr Nipun Verma @drnipunverma

4 days ago

Absolutely what’s needed is here 👇 Thanks for sharing this @ReibergerThomas @BavenoCoop

Thomas Reiberger @ReibergerThomas

4 days ago

Absolutely what’s needed is here 👇 Thanks for sharing this @ReibergerThomas @BavenoCoop

0 2 9 2K 1

Download Image

0 0 1 352 0

Ashwani Singal @singal_ashwani

a week ago

great moment at CMC Vellore in India, with inauguration of a steatotic luver disease clinic. Great institution, attracts patients from all India, excellent medical training, seven campuses, a center of excellence for plasmapheresis in liver failure under leadership of Dr Eapen.